For widespread infectious diseases, vaccination is one of the most effective public health interventions to slow down and prevent severe disease development and death. When the new SARS-CoV-2 virus rapidly developed into a pandemic [1], large efforts were immediately made to develop a vaccine. In December 2020, the first COVID-vaccine BioNTechs produced by Pfizer was approved by the European Medicines Agency and shortly thereafter Astra Zeneca’s vaccine Vaxzevria and Spikevax Moderna were also approved. In Sweden, the first vaccine batches were distributed in December 2020, aimed at-risk groups such as those living in long-term care facilities, adults aged 70 years and older, and healthcare staff who came in contact with potentially COVID-19-infected patients [2]. Gradually more subpopulations became eligible and in early June 2021, everyone aged ≥ 18 years was included in the vaccination programme. The vaccination strategy was deemed effective as 75% of all elderly in long-term care facilities had received a first dose in February 2021 and by mid-July, 70% of the adult Swedish population had received at least one dose [2].
The success of any vaccination programme depends on people’s willingness to receive the vaccination; however, this varies between different groups in society. As reported by the Public Health Agency of Sweden, in April 2021, 91% of all Swedish-born people aged ≥ 80 years had received one vaccination dose, yet a notably lower coverage was observed in same-aged persons from South America (66%), Middle East (62%), North Africa (59%) and Africa, Other (44%) [3]. Similarly, in a general population cohort study (n = 972,723) with national register data extracted in May 2021, immigrants from low- and middle-income countries displayed a fourfold risk of not being vaccinated compared to Swedish-born persons, adjusted for age, sex, income, country of birth, and household composition [4]. Based on the observations of low vaccination coverage in some groups, targeted campaigns were put into effect, but a low vaccination uptake persisted. In another register study with data on sex, occupation, country of birth and vaccination status until November 2022, men and women in white-collar occupations born in a Nordic country displayed a vaccination coverage of 80–90% [5]. The corresponding rates were markedly lower in non-Nordic white-collar men (60–80%) and women (65–85%), and even more so in blue-collar workers born outside the Nordic countries (men: 30–70%; women: 45–70%). Such findings are consistent with several studies done outside Sweden [6].
Vaccination hesitancy is defined as a refusal or delay in getting vaccinated. The decision involves balancing potential benefits, perceived vulnerability, and the likelihood of harm, and can be further influenced by factors such as a sense of urgency and prior negative experiences [5]. Furthermore, some aspects may be specific to having an immigrant background. A review of qualitative studies on vaccination hesitancy in immigrants during the vaccination rollouts for COVID-19, HPV, influenza, hepatitis B, and pneumococcal infections, found several determining factors such as a lack of knowledge of the vaccine’s existence and function, misinformation, distrust of official institutions and cultural bias [7]. Among these findings, a lack of knowledge of the existence of a vaccine and its main benefits could be considered especially alarming.
Immigrants’ lesser access to information from official institutions is a recurring theme [8, 9] and relates to a lack of “health literacy” [10, 11]. Health literacy is a concept that reflects the ability to spread and obtain information that can promote and protect health. During the early conceptualization of health literacy, it focused on the individual’s ability to find, understand, and apply information that can enhance decision-making about health and disease prevention [12]. With time the concept expanded and came to include organizations and their responsibility to help people in their target population to navigate, understand, and use information and services. The emphasize on organizations arouse from observations that health care organizations would commonly miscommunicate important health information to people outside the majority society, leading to poor patient care [13]. By developing health literate organizations, which includes the organization’s linguistic and cultural competence and proficiency for communication, the negative consequences from individual patients' lack of health literacy can also be reduced
In a recent interview study, not knowing the existence and role of official public health and healthcare outlets and lack of information from such official organizations in other languages than Swedish contributed to a lack of access to COVID-19 information among foreign-born persons [14]. In contrast, among students enrolled in the “Swedish for Immigrants” programme, to whom information on COVID-19 was spread through established channels and in several languages, the majority of the respondents reported that they had received adequate information and were informed about protective actions and the current development of COVID-19 in Sweden [15].
Despite consistent evidence of less access to vital public health information and a lower vaccination uptake among immigrants, little is known the extent to which this affects the decision to accept a vaccine. A systematic review study from 2018, focusing on non-interactive communication, found that age and the country in which the vaccination program was conducted were the most decisive factors for accessing information about a vaccine [16], but information from immigrant groups was lacking. Another review study, covering several vaccination programmes including the SARS-CoV-2 vaccine rollout [17], merely found associations between health literacy and influenza vaccination uptake in persons aged 65 years and older. Out of 21 included studies, one investigated American Hispanic woman, but failed to find any association between health literacy and attitudes to the influenza vaccination. This study did not specify if these women were foreign-born or born in America, which is relevant for language sufficiency and knowledge of local healthcare systems.
In Sweden, as well as internationally, vaccination hesitation among foreign-born persons has been observed despite extensive efforts to spread information about the existence and benefits of the vaccine. Nevertheless, little is known about the underlying reasons for not taking the vaccine, especially as told by people from this sociodemographic group themselves. This explorative qualitative study aims to investigate perceptions of health literacy, information access and hesitancy towards taking the COVID-19 vaccine in foreign-born persons living in Sweden.